Blood-to-tissue transport of [18F]2-fluoro-2-deoxyglucose (FDG) and e IC]O-methylglucose (CMG) was compared by dynamic positron emission tomography in four patients with recent ischemic infarcts and in three patients with intracerebral tumors. Local blood volume, tracer transport from tissue to blood, and FDG phos phorylation rates were also determined. A regional anal ysis of parametric images showed a close correlation of FDG and CMG transport rate constants in pathological tissue. Transport rates of FDG and CMG showed corre spondingly less asymmetric remote effects than FDG phosphorylation rates. Transport rate constants were
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The fluorodeoxyglucose technique was originally developed and validated for measurement of re gional glucose metabolism in intact brain tissue (Sokoloff et aI., 1977; Reivich et aI., 1979; Phelps et aI., 1979) . It is based on a single measurement of tissue activity by autoradiography or positron emis sion tomography (PET) with e 8 F]2-fluoro-2deoxyglucose (FDG). The proportion of phosphor ylated FDG in total tissue activity cannot be sepa rately measured in that approach, and must be es timated by assuming fixed rate constants for FDG transport (from plasma to tissue and reverse) and phosphorylation.
Dynamic PET opened a way to determine the re gional rate constants for transport and phosphory lation by nonlinear regression analysis (curve fit-consistently higher for FDG than for CMG in pathological and normal tissue, in accordance with the higher affinity of carrier enzymes to FDG. There was a significant cor relation between fitted regional blood volume values and correspondence of average absolute values with both tracers. It is concluded that dynamic FDG PET for mea surement of cerebral glucose metabolism is also useful to measure alterations of hexose transport and local blood volume in pathological tissue. Key Words:
ting) of sequential tissue uptake data. Measurement of regional rate constants may be essential for mea surement of glucose consumption in pathological tissue where the assumptions of the autoradio graphic approach may not be maintained (Hawkins et aI., 1981; Heiss et aI., 1984; Kato et aI., 1984; Reivich et aI., 1985; Lammertsma et aI., 1987) . However, it has not yet been demonstrated that rate constants determined by regression analysis of re gional tracer uptake curves with dynamic PET ac tually measure those processes (transport and phos phorylation) to which they are ascribed in the model. Rather, they have sometimes been regarded as helpful mathematical constructs for quantifica tion of glucose metabolism, but without their own physiological significance.
The present study therefore examines the validity of hexose transport measurements with dynamic PET by comparing FDG data with independent measurements of the same patients using the non metabolizable glucose analogue [II C]O-meth ylglucose (CMG). Particular attention was paid to alterations of hexose transport in infarcts and brain tumors, where such changes may affect the as sump-tions underlying the calculation of glucose meta bolic rates from FDG uptake. The effects of func tional deactivations on hexose transport were also analyzed with both tracers.
PATIENTS AND METHODS
The study was performed on four stroke and three tu mor patients. Their ages ranged between 47 and 73 years, and three were male, four were female. Informed consent was obtained from each patient. Pertinent clinical data are given in Table 1 . All patients were in a clinically stable state, and the maximum time interval between the two tracer applications was 24 h.
All studies were carried out in a resting state with eyes closed, ears unplugged in a room with dimmed light and low steady background noise caused by the technical equipment. FDG was prepared by the method of Ido et al. (1977) , CMG by the method of Kloster et al. (1981) the first 2 min after arrival of the tracer peak in brain with subsequently increasing time intervals between samples.
A Scanditronix PC 384 (Uppsala, Sweden) tomograph with seven slices and standard image reconstruction soft ware as described in previous papers (Heiss et al., 1984) was used.
The patient's heads were comfortably positioned using a vertical laser beam with the lowest slice coinciding with the canthomeatal line. Repositioning was facilitated by marking the laser line at the first examination with a soft pencil on the patient's skin. Plasma glucose levels did not differ significantly between both measurements (Table O. Data were acquired and analyzed over a total time of 40 min with scan durations ranging between 1 min at the beginning and 5 min at the end of each study.
The FDG model included av ascular, precursor and metabolic compartment, as described by Hawkins et al. (1986) . However, dephosphorylation (k4) of FDG was ne glected because total measurement time was <45 min (Nelson et al., 1986) . The metabolic compartment was omitted for the nonmetabolizable tracer CMG (Jay et al., 1987) .
Local blood volume (BV-FDG and BV-CMG for FDG
and CMG studies, respectively), the rate constants of tracer transport from blood to brain (K1-FDG and Kc CMG) and reverse (k2-FDG and k2-CMG), the phosphor ylation rate constant (k3-FDG), and the CMRGlu (with lumped constant = 0.418) were calculated by nonlinear least-squares fits of the respective model equations to the measured data on a pixel-by-pixel basis. Fits included weighting for data accuracy, as estimated from the num ber of total counts in the respective tomograms (Budinger et al., 1977) , and integration of the model equation over each scan time interval. Sequential tomograms were pro cessed by a nonstationary contrast-preserving low-pass filter to improve the signal-to-noise ratio before fitting. The technical details of this procedure, which produces tomographic images of all parameters, have been de scribed in a separate recent paper (Herholz, 1988) .
Identical geometrically defined regions of interest were placed on normal brain tissue in FDG and CMG tomo grams using standard a scheme provided by a semiauto matic mapping procedure . 
RESULTS
At visual inspection the parametric images of glu cose metabolism showed generally better contrast between pathological and normal tissue than trans port (K1) images. All brain infarcts (patients 1-4) showed decreased glucose metabolism and de creased hexose transport. The malignant tumors showed heterogeneous metabolism, in two cases with areas of higher phosphorylation than normal gray matter. The anaplastic astrocytoma (patient 5) was hypermetabolic in most of its parts (average krFDG = 0.058 versus 0.027 min -I in normal tis sue), but transport rate constants of FDG and CMG were close to the corresponding values in normal tissue ( Table 2 ). The squamous cell carcinoma me tastasis of patient 6 showed a central necrosis with a low FDG and CMG transport and low glucose consumption. Around this necrosis was a rim with increased metabolism and contrast enhancement in X-ray CT, but normal or even slightly decreased FDG and CMG transport (Fig. 1) . The undifferen tiated carcinoma metastasis of patient 7 showed a large hypodense area in X-ray CT with decreased glucose metabolism and decreased FDG transport. The CMG transport rate images appeared very uni form in this case and showed only a slight decrease of CMG transport in the pathological area. Within the tumor an islet of higher transport of both tracers and higher metabolism, approximately correspond ing to the level of normal brain tissue, could be identified. This part showed also higher X-ray den sity in X-ray CT.
There was a close rank correlation between K 1-CMG and K1-FDG in pathological regions (Spear man's rho = 0.85, p < 0.0001, n = 18; Fig. 2) in correspondence with visual image evaluation. How ever, FDG transport rates were consistently larger than those of CMG in pathological and normal tis sue (Tables 2 and 3). The difference between FDG and CMG transport rates was highly significant in Wilcoxon's sign rank test on all regional values (p < 0.0001 for K I and k2' respectively).
Clearly visible crossed cerebellar inactivations were present on parametric images of glucose me tabolism of three patients (patients 2, 3, 5). They corresponded to krFDG reduction of >20% rela tive to the ipsilateral hemisphere ( Table 3) . Asym metries of transport rates were always <20% with CMG and FDG. A marked asymmetric metabolic inactivation of the ipsilateral hemisphere was ob served in patient 5 with the anaplastic astrocytoma, also corresponding to a 20% reduction of kr FDG, but much smaller asymmetries of K,-CMG and K, FDG ( Table 3) . Despite the fact that remote effects on FDG and CMG transport rates were generally small, there was still a highly significant rank correlation be- tween hemispheric inactivations (expressed in per cent of unaffected side; Table 3 ) of FDG and CMG transport rate constants in cerebral cortex and cer ebellum (Spearman's rho = 0.76, p = 0.0015, n = 14). The corresponding rank correlation coefficient between side differences of transport and phos phorylation of FDG (K I "FDG and krFDG) was considerably smaller (rho = 0.42, n.s.).
Parametric images of local blood volume showed the major vessels as the most prominent features in the FDG and CMG studies, respectively (Fig. 1) . Cortical structures, e.g., in the main middle cere- bral artery distribution territory, showed higher blood volume than subcortical white matter. In farcts did not show distinct blood volume alter ations. The X-ray low-density area of the undiffer entiated carcinoma metastasis (patient 7), the ne crotic tumor core of patient 6, and also the central part of the anaplastic glioma (patient 5) showed de creased blood volume. In contrast to transport rates, there was no systematic difference between regional blood volume values determined with FDG and CMG in normal and pathological tissue. Normal brain tissue showed only little regional variation of transport rates. The global regional rank correlation coefficients between transport rates for FDG and CMG were therefore rather low (0.39 for K1, 0.13 for k2), indicating that random fluctuations dominated over regional effects other than asymmetric inactivations. The global rank cor relation coefficients between blood volume mea surements with CMG and FDG were 0.51 in normal brain, 0.63 in pathological tissue, and 0.71 in major vessel regions (p < 0.005 for all tissue types).
Various ratios of transport rate constants were analyzed to determine whether there were differ ences in the relation of FDG and CMG transport between normal and pathologic tissue and between inward and outward transport ( Table 4 ). The al ready noted higher transport rates of FDG resulted in median FDGICMG ratios of �2 with slightly higher values for inward (KrFDGIKrCMG) than for outward transport (k2-FDGlk2-CMG). Analysis of variance of the patient median transport ratios, however, revealed only a significant intersubject variation (F 6. 1 9 = 5.00, P = 0.0128), but no signif icant difference of transport ratios between patho logical and normal tissue (p = 0.52) or between inward and outward transport (p = 0.46). Essen tially the same result was obtained by analysis of K/k2 ratios; although this ratio was somewhat higher for FDG than for CMG (Table 4) , the differ ence did not reach significance in analysis of vari ance (F1 .19 = 3.88, P = 0.063). Thus, our data in- dicate preservation of the relation between FDG and CMG transport in pathological tissue, and do not provide clear evidence of transport asymme tries.
DISCUSSION
The most significant finding of this study is the close correlation between the transport rate con stants of FDG and CMG in pathological tissue. Thus, nonlinear least squares analysis of FDG up take curves provides reliable data on alterations of hexose transport in pathological tissue.
There has been some concern about the validity of FDG measurements in pathological tissue, be cause the relation between transport and phosphor ylation and enzyme affinities to glucose and FDG that are included in the model as a "lumped constant" (Sokoloff et aI., 1977) may change. In particular, a considerable increase of the lumped constant is to be expected if transport becomes the rate limiting step (Crane et aI., 1983; Gjedde et aI., 1985) . Under the assumption that the FDG/glucose ratios of the transport and phosphorylation affini ties would remain constant, a correction for the variation of the lumped constant would be feasible (Phelps et aI., 1983) .
The present results confirm the preservation of the relation between active transport rate constants of CMG and FDG in pathological tissue. Because BBB transport of CMG is very similar to glucose transport (Oldendorf, 1971 ; Gjedde and Diemer, 1983) , it may be inferred that the relation of the transport rates of FDG and glucose is also pre served in pathological tissue. Whether the relation of glucose and FDG affinity to hexokinase is also preserved, however, cannot be answered by the present study. In vitro measurements indicate that there are differences in the relation of glucose and FDG affinities between hexokinase isoenzymes, and changes of the isoenzyme pattern were ob served, at least in tumors (Dominguez et aI., 1987) . Thus, the present data do not provide a complete basis to correct for a possible variation of the lumped constant in pathological tissue.
The range of published values for FDG rate con stants is large, and the present values tend to be at the lower end of that range. This is probably due to the fact that metabolism of normal brain structures in our patients was impaired due to the disease, and that the geometrically shaped regions of interest in cluded more white matter than did the regions used in a previous study (Heiss et aI., 1984) . Median blood-brain and brain-blood transfer constants (K 1 and kb respectively) were significantly larger for FDG than for CMG, indicating a higher affinity of FDG to the carrier enzymes than CMG. The mag nitude of this effect (inward transport ratio 2.24, outward 1.97 in normal tissue) corresponds roughly to observations of Oldendorf (1971) , who measured a brain uptake index of 46 for 2-deoxY-D-glucose versus 29 for 3-0-methyl-D-glucose (ratio 1.59) and it is close to the K1 ratio of 2.33 measured experi mentally by Gjedde (1982) in the rat. The higher brain uptake of FDG also explains the fact that the visual quality of parametric K1-FDG images was not inferior to those of CMG, despite the additional variable (phosphorylation rate constant) that was extracted from the FDG data.
We did not find clear evidence of asymmetric hexose transport across the blood-brain barrier, as suggested by Brooks et ai. (1986) . This may be due to a lack of sensitivity because of large intersubject variation of transport ratios and the small number of patients. In accordance with experimental data (Jay et aI., 1987) we did not include a phosphorylation rate constant, k3' in the analysis of CMG data, whereas Brooks et ai. (1986) suggested that CMG would be metabolized. However, the only evidence for CMG metabolism presented by these authors was the observation that adding an additional rate constant improved the curve fits. The modeling dif ferences could therefore also account for the differ ent findings with respect to transport symmetry.
The lesser reduction of FDG and CMG transport than FDG phosphorylation in remote deactivated areas is in accordance with the results of a previous study by Wienhard et ai. (1985) in which alterations of KrFDG were also seen only in severely deacti vated tissue.
Use of CMG has been suggested for clinical mea surement of hexose transport in brain (Feinendegen et aI., 1986) . The present data indicate that alter ations of hexose transport in deactivated and patho logical tissue can also be measured with dynamic FDG PET with the advantage of additional informa tion on glucose metabolism. Sampling of arterial blood instead of arterialized venous blood should further enhance the accuracy and reliability of the method (Hawkins et aI., 1986) , and reduce the sig nificant intersubject variation of FDG/CMG trans port ratios.
